SynthesisInternational ophthalmology2026
Association between rheumatic diseases and glaucoma risk: a systematic review and meta-analysis of 5.7 million individuals.
Synthesis in International ophthalmology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeSome studies suggest that rheumatic diseases (RD) may be associated with the development of glaucoma; however, findings remain inconsistent. We therefore conducted a meta-analysis to estimate the incidence of glaucoma and assess its risk among patients with RD, to inform evidence-based diagnostic decision-making.
methodsFollowing a pre-registered PROSPERO protocol (CRD42024604067), we performed a systematic search of PubMed, the Cochrane Library, and Embase. Pooled incidence estimates, odds ratios (ORs), and 95% confidence intervals (CIs) were calculated using RevMan 5.4 and STATA 15.0.
resultsEighteen studies comprising 5,766,143 participants were included. RD was significantly associated with glaucoma. The pooled incidence of glaucoma among patients with RD was 4% (rate = 0.04; 95% CI, 0.03-0.06; P < 0.001). By study design, incidence/prevalence estimates were 3% in cohort studies, 9% in case-control studies, and 8% in cross-sectional studies. Compared with the general population, individuals with RD have a 66% higher risk of developing glaucoma (OR = 1.66; 95% CI, 1.15-2.40; P = 0.007).
conclusionBoth the incidence and risk of glaucoma are elevated in patients with RD. These findings highlight the importance of increased ophthalmologic surveillance in this population.
Indexed as
Identifiers
42907678What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.